Highlights
- Blue Trust Inc. increased its investment in Align Technology (NASDAQ:ALGN) by 41.4% in Q4.
- Align Technology shares opened at $214.75 with a 52-week range of $196.09 to $335.40.
- Analyst ratings for Align Technology reveal a moderate buy consensus, with price targets adjusted recently.
Investment Activities
The recent Form 13F filing with the SEC revealed that Blue Trust Inc. elevated its stake in Align Technology, Inc. by 41.4% during the fourth quarter. The firm possessed 803 shares valued at $167,000 by the end of the period, demonstrating increased confidence in the medical equipment provider's prospects.
Other investment firms have shown similar interest in Align Technology. For instance, True Wealth Design LLC expanded its position significantly by 10,700% in the third quarter, while Neo Ivy Capital Management acquired a new stake altogether. CVA Family Office LLC, Mather Group LLC., and Versant Capital Management Inc also increased their holdings substantially during this timeframe.
Market Performance
Shares of Align Technology (NASDAQ:ALGN) began trading at $214.75 on a recent Wednesday. The shares fluctuate within a 52-week range between $196.09 and $335.40. The company holds a market capitalization of $16.03 billion, with a P/E ratio of 36.65 and a price-to-earnings-growth ratio of 4.80, indicating a balanced growth trajectory. The stock's beta stands at 1.67, reflecting its volatility in relation to the broader market trends. Additionally, the 50-day and 200-day simple moving averages are recorded at $222.45 and $226.48, respectively.
About Align Technology
Align Technology, Inc., known for designing and manufacturing Invisalign clear aligners, alongside iTero intraoral scanners, serves orthodontists and dental practitioners globally. The company's product portfolio includes packages geared towards comprehensive orthodontic care for varying age groups, demonstrating their expansive market reach and adaptation to patient needs.